New measurements to guide radiation therapy

December 19, 2017

WASHINGTON, D.C., December 19, 2017 -- When ionizing radiation passes through living tissue, it interacts with molecules present in the cells, stripping away electrons and producing charged species known as ions. Ionizing radiation used for cancer treatment includes gamma rays, X-rays and energetic particles such as alpha and beta rays.

The electrons produced by this process, known as secondary electrons, can themselves go on to wreak further havoc, causing even more dramatic changes. This week in the Journal of Chemical Physics, from AIP Publishing, a group of investigators reports studies of the impact of secondary electrons on a model of DNA.

The measurements were made in a condensed-phase environment. Compared to isolated electron-molecule experiments, the condensed-phase measurements are made under conditions closer to those found in living tissue. The results will be used to accurately calculate the damage and radiation dose delivered to patients in radiotherapy, when cancer cells are bombarded with ionizing radiation.

Secondary electrons are the most important species created by ionizing radiation in living tissue. These "low energy electrons," or LEEs, interact with biological molecules, sometimes breaking them into fragments. One of the affected molecules is deoxyribonucleic acid, or DNA, the molecule that carries genetic code. The long, chainlike DNA molecule consists of a ladder of base pairs connected to each other through a deoxyribose phosphate group.

The precise way LEEs interact with portions of the DNA molecule, the bases themselves or the phosphate backbone, is still not precisely understood, although LEEs do have enough energy to initiate DNA strand breaks. This can affect cell function, leading to mutations and even cell death. In this week's report, the investigators employed a model molecule known as dimethyl phosphate, or DMP, to study the interaction of LEEs with the phosphate backbone of DNA.

New radiation treatment methods, currently under development, can precisely target the radiation to specific cancer cells or even specific locations within those cells. This method, known as targeted radionuclide therapy, or TRT, involves the use of molecules labeled with radioactive atoms that are injected into patients and localized in cancer cells. Once in place, the radioactive molecules produce ionizing radiation inside or close to cancer cells. This radiation then goes on to generate localized LEEs.

An important part of the TRT method involves computer simulations used to predict the interactions of LEEs with biological matter and the amount of radiation absorbed by the targeted biomolecules or cells. One of the key parameters in these simulation models are absolute cross sections, which give the probability of interaction between a single LEE and a target molecule. The work reported here represents the first direct measurement of absolute cross sections for the phosphate unit in DNA, values required to calculate strand breaks induced by LEEs.

The DNA present in a living system is surrounded by water and other types of molecules, so studying these processes in a more realistic environment is particularly desirable. In future work, the DNA will be embedded in water and molecular oxygen, known to sensitize cells to radiotherapy.
The article, "Absolute vibrational excitation cross sections for 1-18 eV electron scattering from condensed dimenthyl phosphate (DMP)," is authored by Vincent Lemelin, Andrew Bass, Richard Wagner and Leon Sanche. The article will appear in the Journal of Chemical Physics Dec. 19, 2017 (DOI: 10.1063/1.5008486). After that date, it can be accessed at


The Journal of Chemical Physics publishes concise and definitive reports of significant research in the methods and applications of chemical physics. See

American Institute of Physics

Related Cancer Cells Articles from Brightsurf:

Cancer researchers train white blood cells to attacks tumor cells
Scientists at the National Center for Tumor Diseases Dresden (NCT/UCC) and Dresden University Medicine, together with an international team of researchers, were able to demonstrate that certain white blood cells, so-called neutrophil granulocytes, can potentially - after completing a special training program -- be utilized for the treatment of tumors.

New way to target some rapidly dividing cancer cells, leaving healthy cells unharmed
Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a new way to kill some multiplying human breast cancer cells by selectively attacking the core of their cell division machinery.

Breast cancer cells use message-carrying vesicles to send oncogenic stimuli to normal cells
According to a Wistar study, breast cancer cells starved for oxygen send out messages that induce oncogenic changes in surrounding normal epithelial cells.

Breast cancer cells turn killer immune cells into allies
Researchers at Johns Hopkins University School of Medicine have discovered that breast cancer cells can alter the function of immune cells known as Natural killer (NK) cells so that instead of killing the cancer cells, they facilitate their spread to other parts of the body.

Breast cancer cells can reprogram immune cells to assist in metastasis
Johns Hopkins Kimmel Cancer Center investigators report they have uncovered a new mechanism by which invasive breast cancer cells evade the immune system to metastasize, or spread, to other areas of the body.

Engineered immune cells recognize, attack human and mouse solid-tumor cancer cells
CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia.

Drug that keeps surface receptors on cancer cells makes them more visible to immune cells
A drug that is already clinically available for the treatment of nausea and psychosis, called prochlorperazine (PCZ), inhibits the internalization of receptors on the surface of tumor cells, thereby increasing the ability of anticancer antibodies to bind to the receptors and mount more effective immune responses.

Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells
In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel immune response.

First phase i clinical trial of CRISPR-edited cells for cancer shows cells safe and durable
Following the first US test of CRISPR gene editing in patients with advanced cancer, researchers report these patients experienced no negative side effects and that the engineered T cells persisted in their bodies -- for months.

Zika virus' key into brain cells ID'd, leveraged to block infection and kill cancer cells
Two different UC San Diego research teams identified the same molecule -- αvβ5 integrin -- as Zika virus' key to brain cell entry.

Read More: Cancer Cells News and Cancer Cells Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to